Delivery Order SPE2DB20D3111-SPE2DB25FA9HJ
Award Date 9/8/25
Potential Completion Date 9/9/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,973.43 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease. The contract was awarded on April 24, 2025, with an ultimate completion date of April 25, 2025, and represents a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,267.83 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease. Awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, this firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement. The contract will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,656.74 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 (60-count units), a combination respiratory medication used to treat chronic obstructive pulmonary disease. The award, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this pharmaceutical distributor. The place of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,251.90 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination respiratory medication used to treat chronic obstructive pulmonary disease (COPD). This competitively awarded, firm fixed-price delivery order was issued on September 16, 2025, with an ultimate completion date of September 17, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $2,175.14 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a prescription respiratory medication used to treat chronic obstructive pulmonary disease. The contract was competitively awarded with firm fixed pricing and is classified as a non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 26,...
- The Defense Logistics Agency awarded a $26,582.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation medication used to treat chronic obstructive pulmonary disease. The contract was competitively awarded with no set-aside designation and is set for completion by August 4, 2025. This delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,251.90 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination inhalation medication used in respiratory disease treatment. This firm fixed-price, non-set-aside contract was awarded on August 15, 2025, with an ultimate completion date of August 18, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $9,533.37 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 15, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $7,069.90 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by June 10, 2025. The contract represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework with the...
- The Defense Logistics Agency awarded a delivery order valued at $17,317.57 to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed price, non-set-aside delivery order is scheduled for completion by June 9, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine procurement...